Tokyo: Daichi Sankyo has announced that DATROWAY (datopotamab deruxtecan-dlnk) has been approved in the U.S. for the ...
Expected to begin in 2027, the trials will involve human patients, and the researchers are working to obtain the necessary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback